Inhibition of mitochondrial NADH:ubiquinone oxidoreductase by spinning oscillating magnetic fields causes toxicity in cancer cells

Abstract

Overview

This study investigates the effects of a novel noninvasive Oncomagnetic device (OMD) on cancer cells, focusing on glioblastoma and diffuse intrinsic pontine glioma cells. The core technology involves exposing cells to a spinning oscillating magnetic field (sOMF).

Findings

• Exposure to sOMF from the OMD leads to selective cytotoxicity in glioma cancer cells, providing a promising approach for anticancer therapy that does not rely on chemical toxicity.
• The immediate intracellular target of sOMF is mitochondrial complex I, where persistent inhibition is observed via a mechanism dependent on reactive oxygen species (ROS).
• This inhibition results in:
• Increased production of oxidative stress
• DNA damage
• G1 phase cell cycle arrest
• Caspase-dependent apoptosis
• Importantly, sOMF does not induce these toxic effects in normal human astrocytes and astroglial cells.

Conclusion

The study demonstrates that spinning oscillating magnetic fields have a direct, detrimental effect on the mitochondrial function of cancer cells, leading to cell death through multiple pathways such as oxidative stress and apoptosis. The absence of similar effects in normal cells provides a rationale for the safe clinical use of OMD in future cancer therapies. Please note that this research establishes a clear connection between exposure to certain electromagnetic fields and biological changes relevant to health and safety.